Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Lora Inclan
Clinical Research Coordinator III
Cancer Center Division
Overview
Research
More
Collaboration
(6)
Abhijeet Kumar
Mutual work: 4 Grants﹒5 Proposals
Collaboration Details
Michele Chu-Pilli
Mutual work: 3 Proposals﹒2 Grants
Collaboration Details
Brianna Denton
Mutual work: 4 Proposals﹒3 Grants
Collaboration Details
Carolyn Lane
Mutual work: 2 Grants﹒3 Proposals
Collaboration Details
Patricia Robles Quihuis
Mutual work: 3 Proposals﹒2 Grants
Collaboration Details
Page 1 of 2
Previous page
Next page
Grants
(4)
A Phase 1/2, Open-Label, Dose-Escalation and Expansion Study of the Bruton Tyrosine Kinase-Targeted Protein-Degrader BGB-16673 in Patients With B-Cell Malignancies
Active
·
2022
·
$0 / $277.3K
·
External
cancer,
drug development,
clinical trial,
molecular biology,
oncology
A Dose Escalation and Expansion Study of the Safety and Pharmacokinetics of XL114 in Subjects with Non-Hodgkins Lymphoma
Active
·
2022
·
$0 / $236.5K
·
External
pharmacokinetics,
oncology,
clinical trial,
safety,
dose escalation
A Phase 2 Open-label Study of Loncastuximab Tesirine in Combination with Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Patients with Diffuse Large B-cell Lymphoma (DLBCL) (LOTIS-9)
2023
·
$0 / $188.6K
·
External
lymphoma,
cancer treatment,
immunotherapy,
clinical trial,
drug combination
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Comparing the Efficacy and Safety of Tafasitamab Plus Lenalidomide in Addition to R-CHOP Versus R-CHOP in Previously Untreate
2022
·
$0 / $650.5K
·
External
cancer treatment,
clinical trial,
immunotherapy,
combination therapy,
lymphoma
